Laurence Katznelson

Cedars-Sinai Medical Center — United States

Medicine · Health Sciences

55h-index14.3kcitations211works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(152), Growth Hormone and Insulin-like Growth Factors(89), Adrenal and Paraganglionic Tumors(53), Adrenal Hormones and Disorders(28), Glioma Diagnosis and Treatment(19)

Publications211 total

Learning from the Natural Experiment of the 2024 Intravenous Fluid Shortage
NEJM Catalyst·2025
Consensus on acromegaly therapeutic outcomes: an update
Nature Reviews Endocrinology·2025· 19 citedOpen Access
Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas
Pituitary·2025· 4 cited
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
UNC Libraries·2025· 2 citedOpen Access
Unionization of Graduate Medical Education Trainees: Perspectives From Designated Institutional Officials
Academic Medicine·2024· 1 cited
Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1
The Journal of Clinical Endocrinology & Metabolism·2024· 15 citedOpen Access
7377 CAM2029, Octreotide Subcutaneous Depot, Improves Patient-Reported Outcomes From Standard-of-Care Baseline in Patients With Acromegaly: Interim Results From a Phase 3 Study (ACROINNOVA 2)
Journal of the Endocrine Society·2024Open Access
7376 Efficacy and Safety of CAM2029 in Patients With Controlled or Inadequately Controlled Acromegaly on Standard-of-Care Treatment: Interim Data for the “New to CAM2029” Patient Subgroup in a Phase 3 Study (ACROINNOVA 2)
Journal of the Endocrine Society·2024· 1 citedOpen Access
7373 CAM2029, Octreotide Subcutaneous Depot, Provides Sustained Biochemical Control of Acromegaly: Interim Results From a Phase 3 Study (ACROINNOVA 2)
Journal of the Endocrine Society·2024· 1 citedOpen Access
An open-label long-term Phase 3 study of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly (ACROINNOVA 2): interim analysis of the ACROINNOVA 1 roll-over patients subgroup
Endocrine Abstracts·2024· 1 cited
An open-label long-term Phase 3 study of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly (ACROINNOVA 2): interim analysis of patient-reported outcomes
Endocrine Abstracts·2024
An open-label long-term Phase 3 study of CAM2029 in patients with acromegaly (ACROINNOVA 2): interim analysis of the subgroup of patients 'new to CAM2029' with controlled or uncontrolled acromegaly on standard-of-care treatment
Endocrine Abstracts·2024· 1 cited
A randomised phase 3 trial to assess efficacy and safety of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly
Endocrine Abstracts·2024
#1705024 A Randomized Phase 3 Trial to Assess Efficacy and Safety of a Novel Formulation of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly
Endocrine Practice·2024Open Access
Transcavernous Resection of Adenoma Embedded in Medial Wall in MRI-Negative Cushing Disease
Journal of Neurological Surgery Part B Skull Base·2024· 1 cited
Outcomes of Endoscopic Endonasal Transcavernous Surgery for Pituitary Adenomas: A By-Compartment Analysis
Journal of Neurological Surgery Part B Skull Base·2024
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis
The Lancet Diabetes & Endocrinology·2024· 43 citedOpen Access
Fertility issues in hypopituitarism
Reviews in Endocrine and Metabolic Disorders·2023· 4 cited
Consensus on criteria for acromegaly diagnosis and remission
Pituitary·2023· 157 citedOpen Access
How Many Lives Will You Save? A Mixed Methods Evaluation of a Novel, Online Game for Patient Safety and Quality Improvement Education
American Journal of Medical Quality·2023· 13 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Anne Klibanski(13), Beverly M. K. Biller(11), Maria Fleseriu(9), Шломо Мелмед(8), Mary Lee Vance(8), Mark E. Molitch(7), Pamela U. Freda(6), Christian J. Strasburger(6), David Schoenfeld(6), Edward R. Laws(5), John Wass(5), David R. Clemmons(5), Brooke Swearingen(5), Felipe F. Casanueva(5), Mônica R. Gadelha(5), Andrea Giustina(5), Adriana G. Ioachimescu(5), Anne Klibanski(5), Michael O. Thorner(4), Gudmundur Johannsson(4)